[{"id":"3bbc8909-6663-4104-b1e4-35511534506d","acronym":"","url":"https://clinicaltrials.gov/study/NCT03069508","created_at":"2021-01-18T15:07:18.115Z","updated_at":"2024-07-02T16:37:24.841Z","phase":"Phase 2a","brief_title":"Clemizole HCl for Subjects With Hepatocellular Carcinoma","source_id_and_acronym":"NCT03069508","lead_sponsor":"Eiger Group International, Inc.","biomarkers":" AFP","pipe":" | ","alterations":" AFP elevation","tags":["AFP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AFP elevation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e clemizole"],"overall_status":"Unknown status","enrollment":" Enrollment 12","initiation":"Initiation: 02/13/2017","start_date":" 02/13/2017","primary_txt":" Primary completion: 12/31/2017","primary_completion_date":" 12/31/2017","study_txt":" Completion: 01/31/2018","study_completion_date":" 01/31/2018","last_update_posted":"2017-03-03"}]